Key result
High moderate-to-vigorous physical activity linked to ~44% lower cardiocerebrovascular mortality vs inactivity in hypertension.
Why the study?
The effect of different levels of leisure-time moderate-to-vigorous physical activity against cardiocerebrovascular and all-cause mortality in hypertension was unclear.
Does moderate-to-vigorous physical activity reduce cardiocerebrovascular and all-cause mortality in adult patients with hypertension?
Cohort (n=4,917)
Does moderate-to-vigorous physical activity reduce cardiocerebrovascular and all-cause mortality in adult patients with hypertension?
Answers are grounded in this paper and cite their sources.
In patients with hypertension, engaging in moderate-to-vigorous physical activity of 7.5 to < 15 MET-h/week is associated with the lowest risks of cardiocerebrovascular and all-cause mortality.
Background: Leisure-time moderate-to-vigorous physical activity (MV-PA) has been consistently regarded as a protective factor to prevent and treat hypertension. However, the effect of different levels of MV-PA against cardiocerebrovascular and all-cause mortality in hypertension is still unclear. The aim of this study was to explore the dose relationships of MV-PA on these adverse outcomes in hypertension. Methods: In the National Health and Nutritional Examination Survey (NHANES) from 1999 to 2006, participants with hypertension were enrolled and classified into inactive (0 MET-h/week), low-active (0 < to < 7.5 MET-h/week), and high-active (≥ 7.5 MET-h/week) groups. A multivariate Cox regression analysis was conducted with a hazard ratio (HR) and corresponding 95% confidence interval (CI). To further explore the association between different levels of MV-PA and adverse outcomes, Kaplan-Meier survival curves, subgroup analysis, and restricted cubic spline curves were performed. Results: During a median 10.93-year follow-up, 1,510 and 347 patients had died from any causes and cardiocerebrovascular, respectively. The high-active group had the highest event-free survivals of all outcomes compared with low-active and inactive groups. A multivariate Cox regression analysis demonstrated that the high-active and low-active groups were associated with reduced risks of all-cause [HR: 0.70, 95% CI: 0.60-0.82; 0.76 (0.68-0.86), respectively] and cardiocerebrovascular mortality [0.56 (0.41-0.77); 0.63 (0.50-0.81), respectively] compared with the inactive group. Subgroup analysis and restricted cubic spline curves showed that MV-PA surpassing 15 MET-h/week could decrease the risks of cardiovascular and all-cause mortality with inverse relationships, which was not the case for cerebrovascular mortality, indicating a U-shaped association. Conclusion: Our study suggests that highly active MV-PA of 7.5 to < 15 MET-h/week was associated with the lowest risks of cardiocerebrovascular and all-cause mortality in hypertension.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2022) conducted a cohort in Hypertension (n=4,917). High moderate-to-vigorous physical activity (≥7.5 MET-h/week) vs. Physical inactivity (0 MET-h/week) was evaluated on Cardiocerebrovascular mortality (HR 0.56, 95% CI 0.41-0.77, p=<0.001). High levels of moderate-to-vigorous physical activity reduced the risk of cardiocerebrovascular mortality by 44% compared to physical inactivity in patients with hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: